{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T07:15:58Z","timestamp":1784790958669,"version":"3.55.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:00:00Z","timestamp":1525996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1093\/europace\/euy092","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T11:05:40Z","timestamp":1526036740000},"page":"1218-1224","source":"Crossref","is-referenced-by-count":20,"title":["Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI)"],"prefix":"10.1093","volume":"20","author":[{"given":"Rados\u0142aw","family":"Lenarczyk","sequence":"first","affiliation":[{"name":"Department of Cardiology, Congenital Heart Disease and Electrotherapy, Silesian Medical University, Silesian Centre for Heart Diseases, Silesian Medical University, 9 Curie-Sk\u0142odowskiej St., Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Boveda","sequence":"additional","affiliation":[{"name":"Cardiology \u2013 Cardiac arrhythmias management, Clinique Pasteur, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina H","family":"Haugaa","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Institute for Surgical Research, Center for Cardiological Innovation, Oslo University Hospital, Rikshospitalet, Oslo, Norway"},{"name":"Institute for clinical medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana S","family":"Potpara","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Belgrade, Beograd, Serbia"},{"name":"Cardiology Clinic, Clinical Centre of Serbia, Beograd, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Syska","sequence":"additional","affiliation":[{"name":"The 2nd Department of Coronary Artery Disease, Institute of Cardiology, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"J\u0119drzejczyk-Patej","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Congenital Heart Disease and Electrotherapy, Silesian Medical University, Silesian Centre for Heart Diseases, Silesian Medical University, 9 Curie-Sk\u0142odowskiej St., Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Chauvin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sadoul","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institut Lorrain du Coeur et des Vaisseaux, CHU de Nancy-Brabois, Vandoeuvre les Nancy Cedex, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Dagres","sequence":"additional","affiliation":[{"name":"Department of Electrophysiology, Heart Center Leipzig, Leipzig, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,11]]},"reference":[{"key":"key\n\t\t\t\t20180710050109_euy092-B1","first-page":"iii1","article-title":"Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association","volume":"18","author":"Raatikainen","year":"2016","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180710050109_euy092-B2","first-page":"38","article-title":"Transvenous defibrillation leads: high incidence of failure during long-term follow-up","volume":"14","author":"Dorwarth","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20180710050109_euy092-B3","first-page":"671","article-title":"Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead","volume":"21","author":"Morrison","year":"2010","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20180710050109_euy092-B4","first-page":"1901","article-title":"Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports","volume":"295","author":"Maisel","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180710050109_euy092-B5","first-page":"36","article-title":"An entirely subcutaneous implantable cardioverter-defibrillator","volume":"363","author":"Bardy","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180710050109_euy092-B6","first-page":"944","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180710050109_euy092-B7","first-page":"1657","article-title":"Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry","volume":"35","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180710050109_euy092-B8","first-page":"494","article-title":"Which patients are not suitable for a subcutaneous ICD: incidence and predictors of failed QRS-T-wave morphology screening","volume":"25","author":"Olde Nordkamp","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20180710050109_euy092-B9","first-page":"1605","article-title":"Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS Registry","volume":"65","author":"Burke","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180710050109_euy092-B10","first-page":"308","article-title":"Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement","volume":"20","author":"Mithani","year":"2018","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180710050109_euy092-B11","first-page":"753","article-title":"Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy","volume":"163","author":"Olde Nordkamp","year":"2012","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180710050109_euy092-B12","first-page":"1434","article-title":"Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey","volume":"18","author":"Boveda","year":"2016","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180710050109_euy092-B13","article-title":"Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey","author":"Boveda","year":"2018","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180710050109_euy092-B14","first-page":"632","article-title":"Periprocedural antibiotic prophylaxis for cardiac implantable electrical device procedures: results from a Heart Rhythm Society Survey","volume":"3","author":"Basil","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"key\n\t\t\t\t20180710050109_euy092-B15","first-page":"458","article-title":"Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association","volume":"121","author":"Baddour","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180710050109_euy092-B16","first-page":"1236","article-title":"2012 EHRA\/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management","volume":"14","author":"Daubert","year":"2012","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180710050109_euy092-B17","first-page":"159","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"18","author":"Wilkoff","year":"2016","journal-title":"Europace"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/20\/7\/1218\/25137663\/euy092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T05:01:43Z","timestamp":1531198903000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/20\/7\/1218\/4995216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,11]]},"references-count":17,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,5,11]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euy092","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,5,11]]}}}